Antitrust Antitrust

US DOJ finds companies' collaboration on standards for collecting Covid-19 plasma 'procompetitive'

By Khushita Vasant
  • 12 Jan 2021 20:32
  • 13 Jan 2021 02:47
The US Department of Justice's Antitrust Division today said that a proposed effort by four companies to collaborate on standards for collecting Covid-19 plasma has "several procompetitive justifications."

The DOJ said in a business review letter to the companies that it has no intention to mount an antitrust challenge against them for efforts

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News